What is Sanara MedTech Inc.'s D&A?

Sanara MedTech Inc. (SMTI) reported D&A of $587.25K in Q1 2026.

How has Sanara MedTech Inc.'s D&A changed year-over-year?

Sanara MedTech Inc.'s D&A decreased by 15.4% year-over-year, from $694.03K to $587.25K.

What is the long-term trend for Sanara MedTech Inc.'s D&A?

Over 4 years (2021 to 2025), Sanara MedTech Inc.'s D&A has grown at a 50.8% compound annual growth rate (CAGR), from $596.98K to $3.09M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Sanara MedTech Inc. SMTI D&A

D&A at other companies

Xtant Medical HoldingsXTNT

$534K-50.3%

Globus MedicalGMED

$29.53M-55.3%

MiMedx GroupMDXG

$301K+204%

BioventusBVS

$1.11M-30.5%

CONMEDCNMD

$8.7M0.0%

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$27.8M+18.6%

Gross profit$25.9M+19.8%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Balance sheet

See full

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Cash flow

See full

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Valuation

See full

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Profitability

See full

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Returns & leverage

See full

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sanara MedTech Inc.'s D&A?: Sanara MedTech Inc. (SMTI) reported D&A of $587.25K in Q1 2026.
How has Sanara MedTech Inc.'s D&A changed year-over-year?: Sanara MedTech Inc.'s D&A decreased by 15.4% year-over-year, from $694.03K to $587.25K.
What is the long-term trend for Sanara MedTech Inc.'s D&A?: Over 4 years (2021 to 2025), Sanara MedTech Inc.'s D&A has grown at a 50.8% compound annual growth rate (CAGR), from $596.98K to $3.09M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.